Bayer AG ADR — AMBELVIST (gadoquatrane) · Contrast-enhanced magnetic resonance imaging (MRI).
Run-up into the decision (T-120 → T+5)
Daily close, T-120 (12/29/25) through T+5. Run-up high $14.4 on 2/19/26, low $9.88 on 6/2/26 (T-120 to T-1). FDA decision 6/15/26. Historical price action, not a forecast.